Octreotide Acetate (West-Ward Pharmaceuticals Corp.)


Welcome to the PulseAid listing for the Octreotide Acetate drug offered from West-Ward Pharmaceuticals Corp.. This Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: West-Ward Pharmaceuticals Corp.
NON-PROPRIETARY NAME: Octreotide Acetate
SUBSTANCE NAME: OCTREOTIDE ACETATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA]
ROUTE: INTRAVENOUS; SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2005-04-04
END MARKETING DATE: 0000-00-00


Octreotide Acetate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionOctreotide Acetate from West-Ward Pharmaceuticals Corp.
LABELER NAME: West-Ward Pharmaceuticals Corp.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(ug/mL)
START MARKETING DATE: 2005-04-04
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0641-6174_61fe5dbc-007f-409d-bc92-3ee11a528678
PRODUCT NDC: 0641-6174
APPLICATION NUMBER: ANDA076313

Other OCTREOTIDE ACETATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Fresenius Kabi USA, LLCOctreotide
Mylan Institutional LLCOctreotide Acetate
Novartis Pharmaceuticals CorporationSandostatin
Sagent PharmaceuticalsOctreotide Acetate
Sandoz IncOctreotide Acetate
Teva Parenteral Medicines, Inc.Octreotide Acetate
West-Ward Pharmaceuticals Corp.Octreotide Acetate
Wockhardt LimitedOctreotide acetate
Wockhardt USA LLC.Octreotide acetate